ClinConnect ClinConnect Logo
Search / Trial NCT01142830

Incidence of Pain After Craniotomy in Children

Launched by SAN GERARDO HOSPITAL · Jun 10, 2010

Trial Information

Current as of June 10, 2025

Completed

Keywords

Craniotomy Pain Children

ClinConnect Summary

Research in the adult population has evaluated incidence and severity of post-neurosurgical pain, and effectiveness of different post-neurosurgical analgesic regimens. Several small studies report the prevalence of some period of moderate to severe pain in the first 24 postoperative hours to be from 41 to 84 % of patients. In a prospective single academic medical institution study, adult patients treated with only acetaminophen and modest amounts of opioids on an as needed basis reported moderate to severe pain for the first 2 days after surgery. These findings have supported a growing cons...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and Female children from 1 month to 10 years Of age
  • American Society of Anaesthesiologists Classification (ASA) I-III
  • Scheduled for supratentorial or infratentorial craniotomy
  • Admission to an Intensive Care Unit, Neurosurgery ward or paediatric ward of one of the hospitals included
  • Children whose parents (or legal tutors) have given their informed written consent
  • Exclusion Criteria:
  • Emergency surgery for multiple trauma.
  • Children requiring muscular relaxants during the postoperative period
  • Children whose parents (or legal tutors) denied their own consensus

About San Gerardo Hospital

San Gerardo Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital collaborates with multidisciplinary teams of experienced clinicians and researchers to conduct trials that address critical health challenges. San Gerardo Hospital prioritizes the safety and well-being of its participants while striving to enhance therapeutic options and contribute to the scientific community. Through its rigorous adherence to ethical standards and regulatory compliance, the hospital fosters an environment of trust and collaboration, ensuring that groundbreaking discoveries translate into tangible benefits for patients and the broader healthcare landscape.

Locations

Torino, , Italy

Bergamo, , Italy

Padova, , Italy

Rome, , Italy

Catania, , Italy

Firenze, , Italy

Genova, , Italy

Milano, , Italy

Patients applied

0 patients applied

Trial Officials

Pablo M. Ingelmo, MD

Principal Investigator

San Gerardo Hospital

Marta Somaini, MD

Study Chair

San Gerardo Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials